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Abstract.  HLA class II antigens are heterodimeric 
cell surface glycoproteins that interact with antigenic 
peptides to form complexes recognizable by CD4-posi- 
tive T  cells. During their biosynthesis, class II anti- 
gens are retained in a post-Golgi compartment in as- 
sociation with the invariant chain,  which dissociates 
before class II cell surface expression.  To address 
whether the invariant chain mediates this post-Golgi 
retention,  its transport and assembly were examined in 
cells that do not express HLA class II antigens.  Pulse- 
chase analysis and endoglycosidase digestions showed 
that very little invariant chain proceeded as far as the 
trans-Golgi in class H-negative cell lines.  Immunofluo- 
rescence studies suggested that in these cells the invar- 
iant chain is sequestered in the RER. Gel filtration 
and cross-linking data showed that RER-localized in- 
variant chain is present as trimers or aggregated tri- 
mers.  Multimefization is mediated by lumenal interac- 
tions; a proteolytic fragment of the invariant chain 
corresponding to the lumenal domain remained tri- 
meric as determined by cross-linking analysis.  Similar 
transport and structural characteristics were observed 
for a pool of excess invariant chain in class H-positive 
cells,  suggesting that an excess of invariant chain in 
the ER may be important  for class II antigen  func- 
tion.  These results have important  implications for 
the transport of cellular proteins in general and for 
the role of the invariant chain in class II antigen bio- 
synthesis. 
M 
AJOR histocompatibility complex (MHC) class II 
antigens are heterodimeric glycoproteins found on 
the surface of B lymphocytes, macrophages,  and 
a limited number of other cell types (26).  Class II antigens 
bind peptides, generated by proteolysis and/or denaturation 
of foreign antigens, in such a manner that the class II/peptide 
complex is recognized by antigen-specific,  MHC-restricted 
CD4-positive T lymphocytes (19, 59). 
Intracellularly,  the class II ot and/3 chains associate with 
a third glycoprotein called the invariant chain (13). This mol- 
ecule is a nonpolymorphic, basic transmembrane glycopro- 
tein that is coordinately expressed with class II antigens (36). 
The invariant  chain  gene,  which is unlinked  to the HLA 
complex (7), encodes at least three polypeptides. The pre- 
dominant polypeptide form is referred to as p33.  The p35 
and p41 forms result from alternate  translation  of the pre- 
dominant  mRNA  species  and  alternate  mRNA  splicing, 
respectively (54, 55). The invariant polypeptides are type II 
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transmembrane glycoproteins,  with NH2 termini  facing the 
cytoplasm and COOH termini facing the lumen ofintracellu- 
lar compartments (6, 33, 56). They bear two N-linked  gly- 
cans (perhaps more on p41), both of which are converted to 
the complex type in the trans Golgi, and at least two O-linked 
oligosaccharides  (38, 39). In addition,  invariant chains can 
be modified  by the addition  of a  chondroitin  sulfate  side 
chain  to generate a proteoglycan (17), and  some invariant 
chains  appear to be phosphorylated (51). 
Like most transmembrane proteins,  the ot and/~ chains of 
class II antigens of the human MHC, or HLA, complex and 
the invariant chain are synthesized on polysomes associated 
with the RER. They associate within  10 rain in the RER (31, 
38), an event which is mediated by lumenal interactions  (41). 
The complex is then transported through the Golgi apparatus 
with a half-time  of 30-60 min, as measured by acquisition 
of resistance to digestion by endoglycosidase H (endo H) and 
of charge  heterogeneity  due to addition of sialic  acid (31, 
38). In contrast to most cell surface proteins,  for which the 
rate limiting  step in cell surface expression is exit from the 
RER (35, 46), class II antigens  are delayed in a post-Golgi 
compartment;  the mature orb dimer does not arrive at the 
cell surface until 2-3 h after the ot/~I complex has acquired 
sialic acid (12). During the post-Golgi lag period, the invari- 
ant chain is dissociated from the o~ and/3 chains by proteo- 
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face (1). 
The contribution of the invariant chain to the biosynthetic 
peculiarities of class II antigens is unknown. It is clear that 
it is not required for HLA class II antigen transport to the 
cell surface, as HLA-DR a  and ~ chain transfectants express 
class II on the cell surface equally well in the absence or 
presence of cotransfected invariant chain (49).  The effect of 
invariant chain on the intracellular transport of class II anti- 
gens is less clear. Whereas invariant chain altered the trans- 
port kinetics and glycosylation  of a and ~ chains in microin- 
jected Xenopus  oocytes (8), it did not appear to affect these 
parameters in Balb/c 3T3 transfectants (50).  On the other 
hand, the invariant chain has been shown to functionally 
affect the ability of class H transfectants to process and pres- 
ent at least some intact antigens to antigen-specific/MHC- 
restricted T lymphocytes (53).  The mechanism responsible 
for this functional effect is not known. 
One proposed function for the invariant chain is to serve 
as a signal for HLA class II antigens to be transported to or 
retained within a post-Golgi intracellular compartment (13). 
This compartment may be that in which newly synthesized 
class II antigens intersect the endocytic pathway (11), and in 
doing so interact with endocytosed and processed foreign 
peptides  (20).  Alternatively, the  post-Golgi compartment 
may serve to retain class II molecules before this point. If 
invariant chain mediated localization to this compartment, 
one might expect that it would localize there in the absence 
of HLA class H antigens. Experiments designed to test this 
hypothesis revealed that the vast majority of invariant chain 
is not localized to a post-Golgi compartment in the absence 
of class II antigens, confirming a recent report using trans- 
fectants (50), but rather is retained within the RER. Our data 
further suggest that RER-localized invariant chain is oligo- 
meric, and that similarly localized and oligomerized excess 
invariant chain is present in class II-positive cells. 
Materials and Methods 
Materials 
All chemicals and proteins were purchased from Sigma Chemical Co. (St. 
Louis, MO) unless otherwise noted. Chemicals for electrophoresis were 
purchased from Bio-Rad  Laboratories (Richmond, CA),  and chromato- 
graphic media and supplies were purchased either from Bio-Rad Laborato- 
ries or from Pharmacia Fine Chemicals (Piscataway,  NJ). 
Cells 
The  B  lymphoblastoid cell  lines  (B-LCL)  Swei (DR5,5)  (38),  Jijoye 
(DR2,5) (23), and T5-1 (DR1,3) (18); the class H-negative mutant B-LCL 
P3HR-1 (23, 52) and 6.1.6 (18); the class II-negative T-LCL CEM; the class 
H-negative T-B hybrid cell line 174xCEM.T2 (T2); and its class H-positive 
parent 174xCEM.T1 (TI) (48) were maintained as described (40),  except 
that in some cases, 3-10% iron/transferrin-supplemented calf serum (Hy- 
clone Laboratories, Logan, UT) was substituted for FBS. P3HR-1 was a gift 
of Dr.  R. E. Humphreys  (University of Massachusetts,  Worcester,  MA), 
and 6.1.6 and I"5-1 were gifts of Dr.  D. Pious (University of Washington, 
Seattle,  WA). 
Antisera and mAbs 
The rabbit antisera 247/HSB (anti-class II; 40), O14 (anti-galactosyl  trans- 
ferase; 47), and aCD-Munster (anti-cathepsin D; 22) and mAbs DA6.147 
(anti-DR,*;  21), XD5.All (anti-class  II~; 27), L243 (anti-HLA-DR;  32), 
RL-77 (anti-protein disulfide  isomerase; 25), and 14-4-4s (anti-I-Ek; 44) 
have been described, mAb POP.I4.3  (IgM, K) was prepared by immunizing 
Balb/c mice with a preparation of whole cellular membranes from "1"2. By 
immunoprecipitation and solid-phase RIA it is reactive only with human in- 
variant chain. Rabbit antiserum Matilda was prepared from a female NZB 
rabbit that was injected with material purified from T2 by affinity chroma- 
tography on POP.I4.3-Bio-gel  A50m (Bio-Rad Laboratories) followed by 
gel filtration on Sephacryl $300 in 3-(3-cholamidopropyl) dimethylammonio- 
l-propanesulfonate  detergent.  For some experiments,  Matilda was absorbed 
with the T-LCL CEM (5 x  l0  s cells/rnl) to remove nonspecitic antibodies, 
resulting in MatildacE~.  Rabbit antiserum EQLP was prepared from a rab- 
bit injected with a peptide corresponding to amino acids 12-28 of the invari- 
ant  chain  cytoplasmic  domain,  eovalently  coupled  to  keyhole  limpet 
hemocyanin (Calbiochem-Behring Corp., La Jolla, CA). O14, aCD-Mun- 
ster, and RL-77 were generous gifts of Dr. E. Berger (Universitat Zurich, 
Switzerland),  Dr. T. Braulke (Georg-August-Universitat,  Gottingen, FRG), 
and Dr. C. Kaetzel (Case Western Reserve School of Medicine, Cleveland, 
OH), respectively.  We thank Dr. R. B. Corley and Ms. D. White (Duke 
University,  Durham, NC) for the gift of 14-4-4s supernatant. 
Radiolabeling 
Continuous labeling with [35Slmethionine ([35S]met) was performed essen- 
tially as described (38), except that met-free  DME (Giboo Laboratories, 
Gaithersburg,  MD) and Tran35S-label (>1,000 Ci/mmol; ICN Radioehemi- 
cals, Irvine, CA) were used as medium and radiolabel, respectively. Label- 
ing was performed for 8 h, and cells were either frozen at -70"C or used 
immediately.  Pulse-chase studies were performed as described (1). 
Cell Extracts 
Cells were extracted in 0.15 M NaCI, 0.01 M Tris,  pHT.4 ('IS) containing 
proteinase inhibitors and either 1% Triton X-100 for immunopreeipitations 
(38) or 1% polyoxyethylene-9-1auryl ether (C12E9) for affinity purifications 
(27), as described. In most experiments,  freshly prepared 20 mM iodoacet- 
amide was included in the extraction buffer. 
Immunoprecipitations 
Preclearing of extracts  with normal rabbit serum (NRS) t and Pansorhln 
(Calbiochem-Behring Corp.,  La Jolla, CA) was performed as described 
(38) for 30-90 rain at 4°C. Extracts were immunoprecipitated as described 
for 3-15 h at 4°C with rabbit antisera or mAb supernatants, followed by 
Protein A-Agarose (Calbiochem-Behring Corp.) or rabbit-anti-mouse Ig- 
coated Protein A-agarose.  Immunoprecipitation with NRS or nonspecific 
monoclonal antibody was performed simultaneously as a negative control 
and showed no bands or spots in all cases.  For preclearing with anti-class 
II antibodies,  extracts were precipitated for 4-15 h each with Bio-gel A50m 
beads to which the antibodies XD5.All and DA6.147 were conjugated by 
cyanogen bromide activation (27). 
Electrophoresis 
One-dimensional SDS-PAGE and two-dimensional  PAGE (with nonequilib- 
rium pH gradient electrophoresis in the first dimension and SDS-PAGE in 
the second dimension) were performed as described (38). Molecular weight 
markers were either radiolabeled with 14C (Amersham Corp., Arlington 
Heights, IL) or prestained (Bio-Rad Laboratories or Sigma Chemical Co.), 
and were calibrated against the migration of Coomassie blue-labeled pro- 
tein standards.  In cross-linking experiments, a2-macroglobin, a generous 
gift of Dr.  Paul Roche (Duke University,  Durham, NC), was used under 
nonreducing (360,000 D) and reducing conditions (180,000 D) as a high mo- 
lecular weight marker. 
Fixation, Fluorography, and Autoradiography 
Gels were fixed and fluomgraphed with Enlightning (New England Nuclear, 
Boston, MA) as described (1), and dried and exposed to Kodak X-OMAT 
AR film at -70°C. 
Western Blotting 
The procedure was performed as described (58), except that gels were trans- 
1. Abbreviatior~  u~ed in this paper: DOC, deoxycholate;  DSP, dithic~bis- 
propionic acid N-hydroxysuccinimide  ester; DSS, disuccinimidyl suherimi- 
date; NRS,  normal rabbit serum. 
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blocked in Blotto (5% [wt/vol] powdered milk [Cost-Cutter;  Kroger, Cin- 
cirmati,  OH]/0.05%  [vol/vol]  Tween  20/0.02%[wt/vol]  sodium  azide in 
PBS) for at least I h at room temperature.  Blots were then incubated at 4°C 
overnight with primary  antibody diluted in Blotto. The secondary reagent 
was an mAb that recognizes rabbit IgG, LORG1 (scra-Lab,  Westbury, NY), 
labeled  with 125I using ehloramine  T (27). 
Ethanol Precipitations 
Glycogen  was  added  as  a  carrier to 0.14).2  mg/ml, and  samples  were 
precipitated with a 7-10 times excess of 100% ethanol at -20°C overnight. 
A~nity Chromatography 
The procedure  was essentially as described by Kalner and Cresswell (27). 
Purified  mAbs  or mouse  IgG were  coupled  at  1-2 mg/mi to cyanogen 
bromide-activated  Biogel AS0m,  and  a precolumn  of mouse IgG-Biogei 
AS0m was  used  in tandem with  the desired  affinity column  to remove 
nonspecific material. After washing, bound material was eluted with elution 
buffer (0.1 M Tris/5%[wt/vol]  glycerol pH 11.0 containing detergent),  and 
immediately  neutralized  with solid glycine. 
Endoglycosidase Treatments 
Digestions with endoglycosidases H and F (endo H; ICN Immunochemi- 
cals, endo F; Boehringer Mannheim Biochemicals,  Indianapolis, IN) were 
performed  on ethanol-precipitated  samples as described  (1, 38). 
Gel Filtration 
Affinity-porified radiolabeled material or whole cell extracts in 1% C~2E9, 
with [3H]glucosamine added as an inclusion marker and blue dextran 2000 
as an exclusion marker, were applied directly to a 50 x  2.5 cm column of 
Sephaeryl $300 equilibrated in 0.02 M bicine pH 8.1/0.13 M NaCI (BS) con- 
taining  either 0.1% C12F,9 or 0.5%  (wt/vol) recrystallized  sodium deoxy- 
cholate (DOC; Fisher Scientific, Lexington, MA; 27). The Scphacryl $300 
column was calibrated  in each detergent  with blue dextran 2000 (D; ex- 
cluded),  bovine  thyroglobulin  (TG  or  Th;  667,000),  mouse  IgG  (I; 
155,000),  human  trans~rrin  (Tf;  80,500),  ovalbumin  (O;  44,500),  and 
[14C]lysine or [3I-1]glucosamine (included volume).  The elution positions 
of  detergent  micelles  were  determined  by  the  mobility  of  [9,10(n)- 
3H]palmitic acid (500 mCi/mmol; Amersham Corp.).  By this method, the 
deoxycholate (DOC) micelle eluted in the position of a 10,000-D globular 
protein,  and the CI2E9 micelle as a 140,000-D globular protein. 
Cross-linking 
For purified material, pooled fractions from gel filtration in BS/CI2E9  were 
treated for 30 rain at 4°C with 3,3'-dithio-bis-propipnic acid N-hydroxysuc- 
cinimide  ester  (DSP)  at concentrations  ranging  from 1.5-100  tLg/rnl. In 
some experiments,  DSP was purchased from Pierce Chemical Co. (Rock- 
ford, IL), and required higher concentrations  than the Sigma material to 
achieve similar cross-linking. Cross-linking reactions were stopped by add- 
ing glycine or ammonium chloride to 10 raM, and samples were precipi- 
tated with ethanol,  subjected to nonreducing SDS-PAGE and analyzed by 
autoradiography or Western blotting. For homogenized cellular membranes, 
log phase  cells were pelleted,  washed three  times with  PBS, and  resus- 
pended at 50-100  x  106/ml in 0.25 M sucrose (Ultra-Pure;  Bethesda Re- 
search  Laboratories,  Gaithersburg,  MD),  1 mM sodium bicarbonate/0.5 
mM calcium chloride/1 mM magnesium  chloride/0.02 % (wt/vol) sodium 
azide. Cells were lysed on ice by 50-100 strokes of a 15 ml Potter-Elvejharn 
glass/Teflon homogenizer (Kontes Co., Vineland, NJ) that was driven by a 
drive with an extendible drive shaft attachment  (Tri-R Stir-R model 1(43; 
Cole-Parmer Instrument Co., Chicago, IL). Lysis efficiency was monitored 
Figure 1.  Pulse-chase analysis of invariant chain in presence or absence of HLA class II antigens. T1  (lefi) or T2 (right) cells were pulse 
labeled with [35S]met for 10 rain and then chased for the times indicated. T1 cell extracts from each time point were immunoprecipitated 
with DA6.147 (anti-DRew,  leJi)  and T2 cell extracts with MatildacEu (anti-invariant chain,  right).  Immunoprecipitates were analyzed by 
two-dimensional PAGE. Arrows indicate position expected for processed invariant chain (Ip) in T2 immunoprecipitates. Arrowheads indi- 
cate p35  and p33  (I)  forms of invariant chain present after 24 h. 
Marks et al. lnvariant  Chain Trimers in RER without  Class H  841 by staining with trypan blue, and homogenization  was continued  until <5 % 
of cells were intact. Nuclei and cell debris were pelleted by eentrifugation 
at 900 g for 10 rain. The supernatant was layered over a 0.2-ml cushion 
of 1.58 M sucrose in 3 ram imidazole and mitochondria  were pelleted by 
centrifugation at 2,200 g  for 15  rain. Supernatant and interface were 
pooled, and cellular membranes were pelleted by ultracentrifugation at 
100,000 g. Supernatants, consisting of soluble cytoplasmic  proteins, were 
discarded. Membranes were resuspended in BS and treated with 1.5--400 
t~g/ml disuceinimidyl suberimidate (DSS; Pierce Chemical Co.), a non- 
reducible analogue  of DSP, for 30 rain at 40C. After stopping  the reaction 
with ammonium  chloride as described above, membranes were solubilized 
in Triton X-100 (1% wt/vol) and analyzed by one-dimensional SDS-PAGE 
and Western blotting. 
Proteinase K Treatment 
[35S]met-labeled affinity-purified invariant chain was dialyzed into "IS 
7.4/0.1%C12E9 and digested with 10 ~g/ml proteinase K as described (41). 
Samples were either precipitated with ethanol or fraetionated by gel filtra- 
tion prior to analysis. 
IntraceUular Immunofluorescence 
Log-phase cells were analyzed  essentially as described by Burkhardt et ai. 
(4). Briefly, 103--104  cells were allowed to adhere to poly-L-lysine-coated 
wells of immunofluorescence  slides (Polyseiences,  Inc., Warrington, PA), 
fixed with 2 % (wt/vol) paraformaidehyde  in PBS, quenched with ammo- 
nium chloride, and permeabilized for 1 h with PBS containing 0.01% 
(wt/vol) saponin and 0.25% (wt/vol) bovine skin gelatin (PBS/sap/gel). 
Wells were incubated with mAb supernatant or with ascites or serum 
diluted in PBSIsap/gel  for 1  h, washed with PBS/sap/gel, and incubated with 
fluoresceinated goat anti-mouse immunnglobulin  or rhodaminylated goat 
anti-rabbit IgG (Cappel Laboratories, Malvern, PA) diluted in PBS/sap/gel. 
Slides were washed with PBS/sap/gel, sealed under 10-50% glycerol in 
PBS containing  0.1% phenylenediamine  or 1,4-diazabicyclo-(2,2,2)  octane 
(Polysciences, Inc.) to minimize quenching, and examined under a MRC- 
5000 confocal  microscope  (Bio-Rad  Laboratories) using the EHS filter for 
fluorescein or the GHS filter for rhodamine and photographed from the 
computer-enhanced image using Kodak TMAX-125 film. 
Results 
Invariant Chain Is Synthesized But Not Processed in a 
Class II-negative Hybrid Cell Line 
Invariant  chain  synthesis  was  initially  characterized  by 
pulse-chase analysis in the hybrid cell line T2 (48)i  T2 ex- 
presses no MHC class II antigens due to the deletion of all 
functional genes from the HLA-D region. However, the cell 
does express very high levels of invariant chain. For compar- 
ison, invariant chain associated with HLA-DR antigens was 
analyzed in T1 cells, the HLA class II-positive parental cell 
line  of T2.  Two-dimensional  PAGE  analysis  of immuno- 
precipitates (Fig.  1) indicates that the p33 and p35 forms of 
invariant chain are synthesized in I"2.  However,  very little 
processed  invariant  chain  is  observed,  even after  24  h  of 
chase. Thus, invariant chain oligosaccharides are relatively 
unprocessed in T2 compared with the highly processed gly- 
cans of class II antigen-associated invariant chain in T1. 
To confirm the lack of N-linked glycan processing,  8-h 
[35S]met-labeled invariant chain from T2 and from another 
invariant  chain-positive  class  II-negative mutant  cell line, 
P3HR-1, was treated with endo H. As shown in Fig. 2, virtu- 
ally all of the detectable invariant chain in both cell lines is 
as sensitive to endo H as it is to endo E  Identical results were 
obtained in T2 by Western blotting (not shown), demonstrat- 
ing  that  the  8-h  [35S]met  label  reflected  invariant  chain 
steady  state  levels.  In  contrast,  most  of  the  class  II- 
associated invariant chain from similarly labelled  class II- 
positive  cells  was  resistant  to  digestion  with  endo  H,  as 
found previously (39,  results not shown). 
Invariant Chain Is Localized to the RER in the 
Absence of  HLA Class II Antigens 
The lack of oligosaccharide processing suggested that invari- 
ant chain was retained  in a  subcellular compartment prox- 
imal to the medial Golgi in ceils that lack class II antigens. 
To further localize this compartment,  class H-negative cell 
lines were analyzed by indirect intracellular immunofluores- 
cence using the anti-invariant chain serum Matildacm.  The 
patterns that emerged in T2,  P3HR-1, and a third invariant 
chain-positive class U-negative mutant, 6.1.6, were identical, 
showing intense staining encircling the cell nucleus (Fig.  3 
a). An invariant chain-negative T cell line, CEM, showed no 
such staining. To determine the subcellular compartment to 
which this pattern corresponded, T2 was stained with anti- 
bodies to proteins previously localized to RER, Golgi, and 
lysosomes/endosomes (Fig. 3 b). The invariant chain pattern 
Figure 2. Invariant chain synthesized  in the absence of HLA class 
II antigens remains sensitive to endo H. Invariant chain was affinity 
purified  on POP.I4.3-Biogel from T2 or P3HR-I cells  labeled  for 
8 h with [35S]met, and eluates  were further purified  by gel filtra- 
tion  on  Sephacryl  $300  in  C~2E9. Peak fractions were  ethanol 
precipitated  and either mock-treated (CTL) or digested  with endo 
H or endo E  Products were reprecipitated  with ethanol and ana- 
lyzed  by  one-dimensional  SDS-PAGE.  Positions  of  molecular 
weight markers (kilodaltons)  are indicated. 
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 is identical  to that observed upon staining  with RL-77, an 
mAb recognizing the PER resident protein disulfide isomer- 
ase. In contrast, staining with O14 (anti-galactosyl transfer- 
ase;  trans-Golgi),  otCD  Munster  (anti-cathepsin  D;  lyso- 
somes/endosomes),  or  the  lectin  wheat  germ  agglutinin 
(trans-Golgi  and distal compartments; 60) resulted in pat- 
terns that were completely distinct  from that obtained with 
anti-invariant  chain reagents.  Thus, the invariant chain ap- 
pears to be sequestered in the RER in the absence of HLA 
class II antigens. 
lnvariant Chain Self-Associates in the Absence of 
HLA Class H Antigens 
Retention of invariant chain within the RER could be due to 
any of a variety  of factors.  Misfolded transmembrane pro- 
teins  are often retained within  the RER until  they are de- 
graded  in  lysosomes or in a  RER-associated degradation 
pathway (28, 46). A similar fate is observed for incompletely 
complexed proteins,  such as individual subunits of the T cell 
receptorfCD3 complex (5, 34, 42) or mutants of the vesicu- 
lar stomatitis virus glycoprotein (VSV-G) or influenza hem- 
agglutinin (flu-HA) that fail to associate into trimers (9, 10, 14, 
16,  30),  and for I-IT,A-DR molecules containing  a mutant 
oesubunit (28a). It was therefore possible that invariant chain 
retention in the PER resulted from a failure to fold or oligo- 
merize properly. In addition,  some misfolded or incomplete- 
ly complexed protein  subunits  have  been  shown  to bind 
within the PER to the heat shock-related protein BiP (2, 16, 
24) and it has been proposed that this interaction  results in 
retention  (2).  We were therefore  interested  in determining 
whether invariant chain,  in the absence of class II antigens, 
could be found in association with other molecules. 
Invariant chain from T2 cells labeled for 8 h with [35S]met 
was affinity purified using the mAb POP.I4.3 and analyzed 
by gel fltration and by cross-linking  with the homobifunc- 
tional,  reducible cross-linking  reagent DSP. DOC was used 
in gel filtration due to its small micelle size, but it was found 
that  DSP-mediated  cross-linking  of membrane-bound pro- 
teins  was inhibited  in DOC.  Therefore,  cross-linking  was 
performed after gel filtration  in C~2E9, a detergent  of large 
micelle size in which invariant chain migrated primarily with 
the void volume. 
The  DOC  gel  filtration  profile  of the  [35S]met-labeled 
POP.I4.3  eluate (Fig. 4 a) showed three overlapping  peaks 
of surprisingly  large  molecular  size.  Invariant  chain,  as 
judged by SDS-PAGE (Fig.  4 a, inset) was seen predomi- 
nantly in the second and third peaks,  which eluted with the 
Mr of globular proteins  of 550,000  and 220,000,  respec- 
tively. No other radiolabeled bands migrated with the invari- 
ant chain  in gel filtration,  suggesting a lack of association 
with other proteins. 
Cross-linking of the affinity eluate with increasing amounts 
of DSP resulted in the step-wise appearance of a number 
of high M, bands on SDS-PAGE (Fig.  4 b). A band of Mr 
65,000  was present even in untreated  samples under non- 
reducing conditions and corresponds to a disulfide-linked in- 
variant chain dimer. The most prominent cross-linked band 
migrated with Mr 95,000-106,000,  as would be expected for 
a trimer. Other bands, corresponding in migration  to invari- 
ant chain  tetramers and,  more intensely,  hexamers  (when 
analyzed on a semi-log plot: not shown) were also apparent 
with the addition  of 50-100 #g/ml DSE The end products 
consisted of a mixture of the Mr 95,000 band and higher Mr 
bands.  Thus,  the DOC gel filtration  peaks of Mr 220,000 
and 550,000 probably correlate with cross-linked trimers 
and higher order multimers of invariant chain,  respectively. 
To show that cross-linking  was itself not nonspecifically 
aggregating invariant chain monomers, the [35S]met-labeled 
affinity eluate was denatured by treating  at 42°C for 2 h. As 
shown in Fig. 4 c, the 420C treatment resulted in a shift of 
the DOC gel filtration peak to Mr 80,000-90,000.  When the 
denatured material  was purified  in CnE9 and treated with 
DSP, there were no observable cross-linked products, even 
upon overexposure  of the autoradiograph (Fig. 4 d). Non- 
denatured  invariant  chain  which  had  been  kept  at  4°C, 
treated  with DSP, and analyzed coincidentally served as a 
positive  control.  Thus,  the cross-linked products observed 
with nondenatured  material  are preformed complexes  that 
can be dissociated to monomers  with an apparent  Mr of 
80,000-90,000 in DOC, by treatment  at 42°C. 
Invariant chain aggregation could also have been induced 
by the affinity purification  conditions.  To eliminate this pos- 
sibility,  gel  filtration  and  cross-linking  experiments  were 
repeated using unpurified,  unlabeled T2 cell extracts.  West- 
ern blot analysis of DOC gel filtration fractions  showed that 
unpurified  invariant  chain eluted as a homogeneous peak 
with an  approximate  apparent  Mr of 220,000  (Fig.  5 a). 
Western  blotting  analysis  demonstrated  that  maximally 
cross-linked  unpurified invariant chain migrated with an ap- 
parent Mr of 105,000 by SDS-PAGE (Fig.  5 b), again con- 
sistent with an invariant chain trimer.  No higher order mul- 
timers were observed. Thus, invariant chain trimers exist in 
detergent  extracts  in the absence of affinity purification. 
To determine whether invariant chain  multimers  exist in 
vivo, T2 cell membranes were cross-linked  in the absence 
of detergent.  Total  cellular membranes were treated with 
increasing  concentrations  of disuccinimidyl  suberimidate 
(DSS), a nora'educible analogue of DSP. Western blot analy- 
sis of solubilized  membranes with an anti-invariant  chain 
peptide antibody,  EQLP,  revealed  a shift of the 33,000 Mr 
invariant chain band to a primary  105,000 Mr species with 
increasing amounts of DSS (Fig. 6), again consistent with a 
trimer.  Higher order multimers  were also observed, but to 
a lesser extent than the trimers.  Probing a similar blot with 
an  antibody to a  resident RER protein,  protein  disulfide 
isomerase,  revealed  no  observable cross-linked  products 
(not shown),  demonstrating  that  the invariant  chain  mul- 
timers observed were specific. Thus,  invariant chain is pri- 
marily trimeric in the RER membrane, although some high- 
er multimers  may exist. 
Invariant Chain Multimerization Is Mediated by the 
Lumenal Region 
Invariant  chain  could potentially  self-associate  by interac- 
tions  within  the cytoplasmic, transmembrane,  or lumenal 
domains.  Proteolytic fragments of the invariant chain,  lack- 
ing  the  transmembrane  region  and  cytoplasmic domain, 
were previously shown to result from proteinase K treatment 
of HLA-DR ot~invariant  chain complexes. These fragments 
remained associated with the HLA-DR o~/~ dimer (41). As 
shown in Fig.  7 a, fragments  identical  in two-dimensional 
PAGE mobility to the 21,500 (K1), 19,500 (K2), and 18,000 D 
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 Figure 5. Western blotting analysis ofT2 invariant chain:gel filtration and cross-linking profiles. Unlabeled 1"2 cell extracts were separated 
by gel filtration on Sephacryl $300 in DOC (.4) or C12E9 (B). (A) Fractions were analyzed by SDS-PAGE followed by Western blotting 
using Matilda anti-invariant chain serum. Shown is an autoradiograph of the blot and the profile from densitometric scanning of the 33-kD 
(invariant chain) band. (B) Peak fractions were pooled and treated with DSP at the indicated concentrations. Samples were precipitated 
with ethanol, separated by SDS-PAGE, transferred to nitrocellulose and invariant chain detected with Matilda and t2SI-LORGI. The ar- 
rowhead indicates position of the invariant chain trimer. 
The Journal of Cell Biology, Volume 111, 1990  846 Figure 6.  Cross-linking of T2 invariant chain in cell membrane 
homogenates. Membranes from unlabeled T2 cells were resus- 
pended without detergent and either mock treated or treated with 
increasing concentrations of DSS. After solubilization in Triton 
X-100, samples were precipitated with ethanol and fractionated on 
SDS-PAGE using a 7% acrylamide separating gel. After transfer- 
ring to nitrocellulose invariant chain was detected using affinity 
purified anti-EQLP antibody and  12~I-LORG1 as  secondary re- 
agent. Arrow indicates position of presumed trimer. Arrowheads 
indicate positions of higher order multimers. 
(K3)  proteolytic products  of class  II-associated  invariant 
chain (41) can also be generated from free invariant chain. 
To determine whether the lumenal domain was responsible 
for oligomerization, the smallest fragment, K3, was purified 
by gel filtration and subjected to cross-linking. SDS-PAGE 
analysis (Fig.  7 b)  shows that with increasing amounts of 
DSP, the 18,000 Mr K3 band is cross-linked to a 55,000-D 
form, consistent with the expected size of a trimer of 18-kD 
monomers. A dimer form is observed as an intermediate be- 
tween monomer and trimer forms, but is not observed in the 
absence of cross-linker. This is consistent with the loss of the 
cytoplasmic domain (and the single cysteine residue) by pro- 
teolysis. Thus, invariant chain trimerization can be account- 
ed for by interactions of the extracytoplasmic regions. 
Structure and Localization of  Excess Invariant Chain 
in HLA Class II-positive Cells 
The results described above suggest that in the absence of 
HLA  class  II  antigens,  the  invariant  chain  remains  se- 
questered in the RER and is predominantly trimeric. Cells 
with an invariant chain-positive, class H-negative phenotype 
are, at best, uncommon in vivo (36, 45). However, it is well 
documented that the invariant chain is present in a large ex- 
cess over HLA class Hot and/3 chains in class II-positive 
cells (38, 39). This excess invariant chain could conceivably 
possess similar biosynthetic and structural characteristics to 
invariant chain in class II-negative cells. To determine this 
we analyzed the properties of the excess invariant chain in 
a number of  cell lines expressing HLA class H glycoproteins. 
The intracellular transport of invariant chain in the class 
H-negative T2 cell line was compared by pulse-chase analy- 
sis with that of the excess free invariant chain in TI, the class 
H-positive parent cell from which T2 was derived. Cell ex- 
tracts from each chase period were cleared of HLA class II 
glycoproteins and associated molecules by immunoprecipi- 
tation with two anti-class H mAbs. The cleared extracts were 
then immunoprecipitated with an anti-invariant chain rabbit 
antiserum, Matildacm. Two-dimensional PAGE analysis of 
each immunoprecipitate (Fig. 8) shows that most of the ex- 
cess invariant chain in T1 cells remains in its unprocessed 
form.  Furthermore,  the excess  invariant chain present in 
class H-depleted cell extracts of  two class H-positive B-LCL, 
Swei and Jijoye, was as sensitive to endo H as to endo F (Fig. 
8 B). In addition, the excess invariant chain has a longer half- 
life than that associated with class II molecules in T1 (com- 
pare Fig. 8 with Fig. 1,/eft). Although this is somewhat shorter 
than the invariant chain half-life in T2, it has been shown that 
excess invariant chain can associate with newly synthesized 
ot and/~ chains (31, 39). This would deplete the excess pool 
and thereby shorten the apparent half-life. These results sug- 
gest that excess invariant chain in class H-positive cell lines 
has a  similar biosynthetic profile to that of free invariant 
chain in class H-negative mutants, and are consistent with lo- 
calization proximal to the medial Golgi. 
The localization of invariant chain in class H-positive cells 
was also analyzed by indirect intracellular immunofluores- 
cence. Fixed, permeabilized cells were stained with either 
a  rabbit  anti-class H  antiserum or a  rabbit  anti-invariant 
chain serum. Shown in Fig. 9 are the results using the class 
II-positive  B-LCL  Swei,  the  class  H-negative,  invariant 
chain-negative T-LCL CEM, and the class H-positive/class 
H-negative parent/mutant pairs T0/T2, Jijoye/P3HR-1,  and 
I'5-1/6.1.6. CEM, as expected, does not stain with either an- 
tiserum.  T2,  P3HR-1,  and 6.1.6 are negative with the anti 
class II antiserum, and exhibit a bright, perinuclear staining 
pattern with the anti invariant chain antiserum. In the class 
II-positive cells, class II molecules appear in multiple cyto- 
plasmic vesicles. An identical pattern was observed with the 
monoclonal anti class II antibody XD5,All (not shown), and 
the pattern is  similar to that observed with antibodies to 
cathepsin D  and galactosyl transferase, markers  for lyso- 
somes/endosomes and Golgi, respectively (e.g., see Fig. 3). 
Staining of class  H-positive cells  with the  anti-invariant 
chain antibody resulted in a pattern that overlapped the class 
H-negative cell invariant chain pattern and the class H pat- 
tern, with both vesicular and perinuclear staining. Both the 
class II and invariant chain patterns were consistent among 
eight different class II-positive cell lines (not shown). The 
results suggest that there are two pools of invariant chain in 
class H-positive cells, one that overlaps with HLA class H 
antigens in an intracellular vesicular compartment, and one 
that does not overlap.  The latter pool of "excess" invariant 
chain appears to be present in the RER since its staining pat- 
tern was identical to that observed with an antibody to the 
RER marker, protein disulfide isomerase (see Fig. 3 and data 
not shown), 
To determine whether the excess invariant chain from class 
H-positive cells exhibited an oligomeric structure, extracts 
Marks et al. Inrariant  Chain Trimers in  RER without Class II  847 Figure 7. A lumenal invariant chain fragment re- 
mains  trimeric.  (A)  [35S]Met-labeled invariant 
chain, purified from 8-h [3SS]met-labeled  "1"2  cells 
by affinity chromatography on POP.I4.3-Biogel in 
Ct2Eg, was either mock treated (0) or treated with 
proteinase K at 0.1, 1, or 10 #g/ml as indicated. 
Products were precipitated with ethanol and ana- 
lyzed by two-dimensional PAGE. Arrow in the first 
panel marks presence of the invariant chain pro- 
teolytic product with mobility similar to that of  K1. 
(B) Purified [35S]met-labeled  invariant chain was 
treated with 10 #g/ml proteinase K for 90 min at 
0°C. Aliquots were then applied to Sephacryl $300 
in CI2Eg, and peak fractions were analyzed by 
cross-linking with DSP. Arrows indicate positions 
of the dimeric and trimeric K3 fragments. 
from  8-h  [35S]met-labeled  Swei  B-LCL  were  cleared  of 
class  II  antigens  and  the  remaining  invariant  chain  was 
purified by affinity chromatography. The eluate was  ana- 
lyzed by gel filtration and by cross-linking with DSP. The in- 
variant chain was found to elute with an M, of 220,000 by 
gel filtration in DOC (Fig.  10, a  and b) and treatment with 
increasing  amounts  of DSP  yielded an  end  product that 
migrated with an M, of 100,000 by SDS-PAGE (Fig.  10 c), 
both results consistent with a  homotrimeric structure.  An 
identical pattern was observed for the excess invariant chain 
in the Jijoye B-LCL (results not shown). Thus, as in class II- 
negative mutant cell lines, the excess, class H-unassociated 
invariant chain in class II-positive cells self-associates into 
a trimeric structure. 
Discussion 
One hypothesized function of  the invariant chain is as a trans- 
port and/or retention protein for HLA class II antigens to a 
post-Golgi  intracellular  compartment.  Such  a  hypothesis 
would be supported if it could be shown that invariant chain 
localized to a similar compartment in the absence of HLA 
class II antigens.  The data presented here, however, show 
that invariant chain from class If-negative mutants localizes 
instead to the RER. The N- and O-linked oligosaccharides 
of invariant chain remained unprocessed in class II-negative 
ceils (Figs. 1 and 2), and identical immunofluorescence pat- 
terns were obtained using reagents directed against invariant 
chain and a PER marker, protein disulfide isomerase (Fig. 
3). Similarly, PER-localized invariant chain was found even 
in HLA class H-positive cells (Figs. 8 and 9), corresponding 
to the previously described excess pool (31,  37, 38). Thus, 
efficient invariant chain transport out of the PER appears to 
require association with HLA class II antigens.  Consistent 
results have been obtained in the mouse using a fibroblast 
transfection system (50). However, these data do not a priori 
rule out a role for invariant chain in class II transport or post- 
Golgi targetting once it is complexed with the ot and/3 chains. 
Note that some invariant chain "escapes" the RER in the 
absence of class 1I antigens; a very small amount of process- 
ing was observed by pulse-chase analysis (Figs.  1 and 8 a), 
and punctate staining was observed with anti-invariant chain 
reagents in some T2 and P3HR-1  ceils by immunofluores- 
cence (see Figs.  3 and 9). In addition, certain monoclonal 
and antipeptide antibodies detect small amounts of invariant 
chain on the surface of B cell lines, and we have recently 
been able to detect low amounts on the surface of T2 by im- 
munofluorescence  using POP.I4.3 (Davis, J. E., and P. Cress- 
well, unpublished results). Furthermore, processed invariant 
chain can be isolated from T2 cell extracts using Lens culin- 
The Journal of Cell Biology, Volume 111,  1990  848 Figure 8. Pulse-chase and endnglycosidase  analysis of  excess invariant chain in class lI-posidve ceils. (,4) TI ceils were  pulse labeled with 
3sS-met for 10 rain and chased for the times indicated with an excess of cold methionine. Cell extracts were precleared of HLA class II 
antigens and associated molecules by immunoprecipitation  first with DA6.147 and then with XD5.A11, and cleared extracts were immano- 
precipitated with Matildacw.  Matildacm precipitates were analyzed by two-dimensional PAGE. Arrowheads indicate presence of p35 
and p33 invariant chains after long per/otis of chase. (B) Extracts from 8-h [3SS]met-labeled  Swei or Jijoye B-LCL were cleared of HLA 
class II antigens by passage through L243-, DA6.147-, and XD5.All-Biogel, and then remaining invariant chain was affinity purified on 
POP.I4.3-Biogel in C~2E9. POEI4.3  eluates were further purified by gel filtration on Sephacryl $300 in C~2E9. Peak fractions were 
pooled, precipitated with ethanol, and either mock treated or treated with endo H or endo E Products were analyzed by one-dimensional 
SDS-PAGE. 
aris hemagglutinin, which binds N-linked oligosaccharides 
that have been fucosylated  by the medial Golgi fucosyl trans- 
ferase (29).  However, ,~,10-fold less invariant chain was pre- 
cipitable with this lectin that with rabbit anti-invariant chain 
serum, (results not shown), suggesting that only a small pro- 
portion passes the medial Golgi. In addition, only a small 
amount of  invariant chain is converted to the chondroitin sul- 
fate proteoglycan form in class H-negative, invariant chain- 
positive cells (data not shown), as observed in the mouse 
(50). 
Misfolded proteins  or isolated  members of incomplete 
protein  complexes  are  often  retained  in  the  PER (46).  Some 
are bound by BiP or BiP-like  resident  PER proteins  (2), 
which are themselves retained by possession of an anchor 
signal, such as the KDEL sequence found in a number of 
soluble resident PER proteins (43).  Invariant chain that is 
not associated with class H antigens does not appear to bind 
to any such molecules. In T2, no invariant chain-associated 
proteins were observed by co-immunoprecipitation (Fig.  1) 
or by affinity  chromatography and gel filtration after labeling 
with [ssS]met,  [3I-I]leucine, or silver  staining (Fig.  4  and 
results not shown). Similar results were obtained in a second 
class H-negative cell line, P3HR-1  (results not shown), and 
with the excess invariant chain from class H-positive cell 
lines (Figs. 8 and 10, results not shown). Furthermore, invar- 
iant chain was not observed in anti-BiP immunoprecipitates 
from T2 (Lamb C., and P. Cresswell, unpublished). Thus, 
it appears that association with resident RER proteins is an 
unlikely explanation for invariant chain retention. 
Misfolded  proteins  that  are  not  transported  are  often 
degraded early after synthesis in a RER-associated proteo- 
lyric compartment (5,  34). Invariant chain, however,  has a 
longer half-life in the absence than in the presence of as- 
sociated class  II  antigens,  as  determined by pulse-chase 
analysis (Figs. 1 and 8). Thus, degradation cannot be respon- 
sible for the lack of transport. 
A number of misfolded proteins that are retained within 
the PER have an unusual stoichiometry compared with their 
correctly folded counterparts (46). For example, VSV-G and 
flu-HA normally associate into trimers before exit from the 
RER. Mutants of these proteins that remain as monomers or 
form large nggregates are retained in the RER (3, 9, 10, 16, 30). 
Invariant chain in the absence of MHC class H antigens is 
oligomeric, predominantly existing as a trimer even in intact 
membranes (Figs. 4-6 and 10). Because this result was ob- 
tained both after affinity  purification and by Western blotting 
of unpurified cell extracts, using two different anti-invariant 
chain reagents, all detectable invariant chain in the cell ap- 
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 pears  to be  oligomeric.  Experiments  using  pulse-labeled 
afffinity-purified invariant chain further suggest that trimeri- 
zation is an early event, occurring within 10 rain after syn- 
thesis (results not shown). Such kinetics axe similar to those 
observed for trimerization of the VSV-G protein and flu-HA 
(3, 9). Thus, invariant chain stoichiometry is more like that 
observed for transport-competent forms of the viral glyco- 
proteins than for transport-incompetent forms. Since the ex- 
cess invariant chain trimers in class H-positive cells are capa- 
ble  of associating  with  newly  synthesized MHC  class  II 
antigens (31, 38), this suggests that gross misfolding of free 
invariant chain complexes does not occur. 
Trimerization of  invariant chain is mediated by lumenal in- 
teractions (Fig. 7), indeed by the same region of the mole- 
cule that mediates binding to HLA-DR antigens (41).  Any 
aggregation of trimers must occur via regions outside the 
limits of the soluble K3 fragment digestion product, most 
likely in the transmembrane or cytoplasmic regions, since 
only trimers of K3 were observed upon cross-linking with 
DSP under conditions in which higher order multimers of in- 
tact invariant chain were observed (compare Fig. 4 B with 
Fig.  7). 
Klausner has recently proposed three mechanisms where- 
by proteins are specifically targeted to or retained within 
compartments of the secretory pathway (28). The first two, 
possession of positive transport signals and positive reten- 
tion signals within the primary or tertiary structure ofa poly- 
peptide or glycoprotein, are  active mechanisms  of local- 
ization, requiring receptors to recognize and act upon the 
protein. The third "signal; referred to as transport incompe- 
tence, dictates that some inherent property within the struc- 
ture of the glycoprotein or peptide chain, such as tendency 
to aggregate, hydrophobicity, or some other property, would 
prevent it from achieving a conformation that would allow 
transport to the next step along the secretory pathway. Trans- 
port incompetence by means of aggregation is an attractive 
hypothesis to explain the PER localization of free invariant 
chain.  The higher order multimers of invariant chain ob- 
served when intact membranes were cross-linked (Fig.  6) 
may be indicative of a tendency for trimers to aggregate in 
vivo. As aggregation is most likely dependent on a number 
of environmental factors, such as protein concentration, pH, 
and ionic strength, that could vary within subdomains of the 
PER, the small amount of leakage of invariant chain to the 
Golgi could be explained by slow localized disaggregation 
into trimers. In class H-positive cells, the class I2I glycopro- 
teins themselves may prevent or reverse aggregation of the 
invariant chain,  thus  allowing transport.  Clearly, this  hy- 
pothesis remains to be tested. 
The presence of  excess trimeric invariant chain in the RER 
of class H-positive ceils has implications for the structure of 
the intraceUular class II cz/3-invariant chain complex. It is 
known that the three chains associate within the RER (31, 
37). It is conceivable that trimeric invariant chain may form 
a core for the complex, with ot/$ dimers binding to each in- 
dividual chain of the tdmer. The predicted complex would 
be consistent with the high apparent Mr (",,270,000) previ- 
ously obtained on gel filtration of  purified, accumulated txB- 
invariant chain complexes, at the time ascribed to association 
with the proteoglycan form of  the invariant chain (27). Alter- 
natively, binding of ot and/~ chains to an individual invariant 
chain molecule could disrupt the trimer, resulting in beter- 
otrimers of ~, B, and invariant chains. The stoichiometry of 
intraceUular class II complexes is currently under investi- 
gation. 
The presence of excess invariant chain in the PER of class 
II-positive cells emphasizes the importance of a very early 
association of HLA class II antigens with invariant chain. 
This interaction is important enough for class H expressing 
cells to dedicate a significant amount of energy to making 
a large excess of a protein that is destined, in the absence of 
such an association, to merely occupy the lumen of  the PER. 
Such an adaptation suggests that either (a) class H antigen 
function would be severely compromised in the absence of 
an association with invariant chain, or (b) the presence of  the 
class 11 antigens in the RER or Golgi would be detrimental 
to the cell or the organism. Both possibilities would be con- 
sistent with a role for the invafiant chain in facilitating the 
association of class II proteins with foreign antigenic pep- 
tides (37). This role could be to direct the transport of newly 
synthesized class II antigens to a subcellular compartment in 
which they might encounter foreign peptides or to retain 
class II antigens within this compartment. We have recently 
shown that invariant chain association inhibits the binding of 
peptides to class II molecules, which may be a mechanism 
to ensure that the peptide binding site is not accessible until 
such a compartment is reached (45a). The lack of an observ- 
able effect of invariant chain on class 1I antigen biosynthesis 
in murine fibroblast transfectants (50) would tend to argue 
against a role in transport, but further study of the role on 
invariant chain in class II antigen transport and peptide inter- 
actions is clearly required. 
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Figure 10. Gel filtration and cross-linking analysis of the free pool of invariant chain in Swei B-LCL. [35S]Met-labeled  Swei cell extracts 
were depleted of  class II antigens and associated molecules using L243, DA6.147, and XD5.A11 affinity columns, and remaining free invari- 
ant chain was purified on POP.I4.3-Biogel in C12E9. Eluates were applied to Sephacryl $300 in either DOC (A) or C12F~ (B). Fractions 
were analyzed by SOS-PAGE (A,  inset) and subsequent densitometry of the 33kd invariant chain band. Fraction numbers are indicated 
above the inset. Pooled fractions were analyzed by cross-linking with DSP (B). The mobility of molecular weight markers (kilodaltons) 
is indicated. 
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